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IS IT POSSIBLE TO CURE DIABETES MELLITUS BY 
HERBAL TREATMENT IN TWENTY FIRST CENTURY? 
Purusotam Basnet* 
ABSTRACT 
The diabetes is the由irdleading cause of death in the world.’The diabetic population is increasing day 
by day.百iereport of WHO shows血atthe diabetic population was 60 millions in 1980, 118 millions 
in 1995 and there will be 220 millions in 2010. Therefore, it is very important to focus on the research 
to find the cure to such disease, which is not only killing the lives and deteriorating the health but 
also, a huge social and economical burden to the nation. 
Although some people prefer to say出atdiabetes is a W estem disease, there is already description of 
diabetes in白eoriental literature claimed as 3500 years old. It is one of由巳oldestknown human dis-
eases. So far known, there are more出an1200 hypoglycemic plants already reported組 dmany of 
them are used for the treatment of diabetes in several countries. None of the phytomedicines, so f紅
reported, sufficiently meets the criteria for a medicine such as safety, efficacy, mode of action, 
bioavialibity, dosage, carrier system etc. to be used clinically. 
There紅eseveral scientific evidences for the cause of diabetes mellitus and one m司orcause is the 
gradual destruction of insulin-producing {3 -cels in the pancreas. On this reg紅d,the role of GAD”65, 
IRS, Thl andτ'h2 cels activities, and reactive oxygen spices (ROS) including SOD-activity, have 
been studied. Vitamin C, vitamin E, nicotinamide, lipoic acid, N-acetyl-L-cysteine are some of the 
substances showing the preventive action on diabetes. However, there is no systematic study on血e
role of natural m巴dicinesand their actions in preventing diabetes. 
The main challenge for the natural medicines in 21'1 century is the systematic study. In the present re-
view, an attempt was made to focus on the medicinal plants which are used as a traditional medicine 
in more血antwo countries. Moreover, only a few of them紅etaken to clinical trails. The total litera-
ture survey suggests that the use of hypoglycemic plant remedies clinically requires f町出ersystematic 
study. 
INTRODUCTION 
Diabetes mellitus (DM) is reg紅白das one of the oldest known diseases in human societies. The symp-
toms of diabetes such as polyurea, polyphagea, excessive thrust, weakness, losing weight etc., had already 
been well ilus回tedin Chinese or Indian ancient literature dated back 3500 years (Hengesh拍 dHolcomb, 
1981). The位eatmentfor DM such as exercise, controlled food habit and some herbal remedies had al-
ready been practiced. In spite of al this, DM isoften wrongly referred as a Western disease. In fact, DM 
is the disease related to metabolic disorder, therefore, the food habit and living style are the main cause 
of DM. In an attempt of evidence-based medicine, an epoch-making discovery in 1921, that a pancreatic 
extract (insulin) would lessen the s戸nptomsof diabetes, was a landmark in the紅eaof antidiabetic drugs 
仕omnatural sources. At the time of insulin discovery, it was hoped出atit would be a cure for DM. People 
were disappointed since it took more血an10 ye紅 Sto understand由eproper dose of insulin and it was not 
the actual cure for DM, but way to control the glycemia. However, the treatment of insulin was life saving 
and prolonged the life of those people who have to die early because of ketoacidosis or diabetic compli-
cations. 
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is widely available, more deaths are attributed to diabetes than to cancers or motor vehicle accidents 
(World Health Organization, 1985). It has been considered that DM isthe third leading cause of human 
death in the world. The report of WHO shows that the population of diabetics was 60 millions in 1980, 
118 millions in 1995 and there will be 220 millions in 2020 (Amos et al, 1997). Every year diabetic popu-
lation is increasing in spite of al research and education in this area. More than 10% Japanese population 
of over 40 years is suffering from type I diabetes (NIDDM: Non Insulin Dependent Diabetes Mellitus, 
i.e. insulin is insufficiently produced or hyperinsulinema or insulin does not function properly, however 
external insulin is not required). Although the number of Type I diabetes (IDDM: Insulin Dependent 
Diabetes Mellitus, i.e. insulin can not be produced within the body, therefore external insulin is required) 
population is very low comparing to Western countries, more than 6000 people are suffering from such 
incurable disease in Japan. Therefore, it is very important to focus on the research aim to find cure for 
such disease which is not only killing the lives, but deteriorating health and also a huge social economic 
burden to the nation. Only in USA, direct medical costs due to diabetes are estimated to have been 9.6 bil-
lion US$, and indirect costs for short term morbidity, long-term disability, and mortality are estimated to 
have been 10 billion US$ (Center for Economic Studies in Medicine 1988). The enoロnouscosts of mod-
em treatment indicate that alternative strategies for the prevention and treatment of diabetes must be de-
veloped. Moreover, almost 90% of the people in rural areas of developing countries stil rely on traditional 
medicines for their primary health care. A synthesis of traditional and modern knowledge may lead to ef-
fective and cost-efficient alternatives. 
Whether it is Type I or I, the main cause of diabetes is the loss of f3 -cells either due to toxic chemicals 
from external environment, viral infection or diet. In addition to this, immunological factors such as 
autoimmune disorders have been considered as the focus for the cause of Type I togenetically vulnerable 
individuals (Unger and Foster, 1985). Type I diabetes is generally found in older population and often as-
sociated with obesity. More than 15% of people over 65 years of age have Type I (Ilarde and Tuck, 
1994 ).In Type I, either insulin is excessively produced with its improper function or production of insu-
lin is not sufficient. In both conditions, the patients suffer with an elevated blood glucose level causing 
the metabolic disorder. 
Before the modern therapy, herbal treatment, diet and exercise were the way of treatment for the DM pa-
tients. Such method stil exist as a part of treatment but this treatment is not beneficial to the Type I dia-
betes, although it is often beneficial for the several cases of Type I diabetes. The focus on pancreas has 
been started since 1889 after von Mering and Minkowski who found that pancreas has a great role to co任
trol glycemia. The successful experiment was carried out by Banting and Best in 1921 for the use of pan-
creatic extract, what we cal insulin today, to reduce the elevated blood glucose level, which has been 
considered as the foundation of modern treatment for the diabetic people. Insulin controls the absorption 
of glucose in the intestine, reverses the neoglucogenesis process, activates the hepatic enzymes, activates 
and generates the glucose transporter in the fibroblasts, suppresses the function of glucagon and other hor-
mones, activates the glycogenesis and fat synthesis. All these actions of insulin help to lower the elevated 
glucose level to normal. Therefore, the major concern for the research on diabetes remained mainly to be 
the action mechanism of insulin after its discovery since 1921. Insulin plays a vital role to control the 
glycemia, however, it could not be the total solution to overcome the diabetes. Moreover, insulin being 
a polypeptide (51 aminoacids), the oral route of administration isnot effective, since it is digested in the 
intestine. In addition to this, it has shorter life span in the human body, therefore, its effect is not long last-
ing. On the other hand, the daily pain of using insulin and its difficulty of handling for DM patient 
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encouraged the scientists to discover oral hypoglycemic agents. In the mean time, during World War I 
when insulin was not available in many of由ecountries, search was made for an insulin substitute 合om
plant sources. Soon after the World War I, oral hypoglycemic agents were made available for the clinical・ 
use that exceeds more血an88 types up to now (So吋町toand Famswo此h1989). 
WHY MEDICINAL PLANTS ARE SO IMPORTANT? 
Discovery of insulin together with 88 clinically used oral hypoglycemic drugs did not solve the problem 
of diabetes. Many of the oral hypoglycemic drugs are not effective when由eyare used for long time. 
Because of this reason, people are stil hoping to find a solution for diabetes in natural medicine. Several 
attempts were made to discover the effect of the natural medicine, especially to potentiate the f3 -cells for 
the production of more insulin. Most of the natural medicines were studies for their hypoglycemic effect 
in normal or diabetic animal models. Based on由eph紅macologicaltests, more than 1200 medicinal plants 
were reported for their alleged hypoglycemic effect, however the action mechanism may be di百erent.
Many of the medicinal plants are used traditionally as血eantidiabetic remedy in different cultures. There 
訂estil more researches going on to find more antidiabetic plants. However, no medicinal plants can be 
considered up to now as the evidence based medicine in spite of huge efforts of scientists al over the 
world, as it is hoped that herbal remedy will be a solution for the treatment of diabetes in血efuture. 
Researchers may have individual interest and it should not be limited. However, it should be the matter 
of interest to know why the people in three or more different cultures are using s但nemedicinal herb for 
由esame p町pose.For this reason, ethnomedicines are of great importance. Despite the difficulties, the fi-
nancial rewards of success in marketing plant-derived drugs町egreat. In many developed countries 25% 
of al prescriptions dispensed仕omcommunity ph但maciescontained active principles prepared仕om
plants. Of the 121 natural products currently in ph釘maceuticaluse, only 12% are produced commercially 
by synthesis (Fransworth et al., 1985). Therefore, the medicinal plants are of great value. Several medici-
nal plants yet have to be tested for their antidiabetic activity. Therefore, it can be hoped由atthe herbal 
treatment for the diabetic people would be economically and therapeutically useful. For this aim, the 
plants falling under following general criteria could be useful: 
1. Same medicinal herb using in different ethnic culture for the antidiabetic pu中ose
2. Experimentally known antidiabetic activity in several animal models and clinical trial 
3. Nontoxic within出er姐 geof effective dose 
4. High botanical abundance 
Table 1: Antidiabetic Plants Used as Ethnomedicines in More白anTwo Coun佐ies
Active constituents 
(-)-epicatechin 
diphenylamine 
ca血aran血ine,lochnerine, 
tetrahydroalstonine, 
leurosine sulphate 
vindoline, vindolidine 
Toxicity 
N 
T 
N 
ワ
T 
Route 
po,sc 
po,iv 
po 
po,sc 
po 
ETM Part tested 
rz 
lf,sb,sd 
sd 
rt,wp 
lf 
3 
9 
3 
4 
10 
Scientific n創ne
Alisma orientale 
Anacardium occidentale 
Coriandrum sativum 
Daucus carota 
Catharanthus roseus 
Alismataceae 
Anacardiaceae 
Apiaceae 
Apiaceae 
Apocynaceae 
Family 
????
?????????
wp 
??
???
??
??、
?
Pistia stratiotes 
Arctium Zappa 
Centaurea melitensis 
Neurolaena lobata 
Taraxacum officinale 
Nasturtium officinale 
Araceae 
Asteraceae 
Asteraceae 
Asteraceae 
Asteraceae 
Brassicaceae 
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pectin 
ursolic acid, 
oleanolic acid 
?
?po 
po 
wp 
仕
3 
3 
?????
??
?????。?Cactaceae 
Comaceae 
qua tern紅yalkaloid 
polypeptide p, 
charantin:daucosterol, 
( + )-5,25-stigmastadien-
3β－ol-glucoside 
??
po 
po 
po,sc,iv 
wp 
fr,lf,st,rt 
仕， sd
? ?
???
??
Citrullus colocynthis 
Coccinia indica 
Momordica charantia 
Cucurbitaceae 
Cucurbitaceae 
Cucurbitaceae 
dioscorans a-f 
??
ip,po 
po 
po 
???
?
?
??
?
4 
?
『
?
『
Kyllinga monocephala 
Dioscorea batatas 
Phyllanthus emblica 
Phyllanthus niruri 
Cyperaceae 
Dioscoreaceae 
Euphorbiaceae 
Euphorbiaceae 
lupanine, sparteine 
lupanine, coumarin, 
sparteine 
trigonelline,coumarin 
nicotinic acid 
nicotinamide 
fenugreekine 
???? ? ?????
?????? ???
??
po 
po 
po,sc 
sd,gm 
sd,wp 
sd 
? 、
?、
?? 、
?
Acacia nilotica 
Lupinus albus 
Lupinus termis 
Fabaceae 
Fabaceae 
Fabaceae 
N po sd,wp 4 Trigonella foenum-graecum Fabaceae 
allylpropyl disulphide, 
allicin, diphenylarnine 
allylpropyl disulphide, 
allicin 
Lu pol 
anemarans a-d 
nimbi din, 
daucosterol, flavonol 
glycosides 
daucosterol 
phytosterol glycoside 
scopoletin, moran a, 
glycoproyein, moranoline 
ursolic acid 
?????
po 
SC 
po 
ap 
lf 
lf 
????
? ??
?
Viciafaba 
Fumαria parvijlora 
Juglans regia 
Ajuga iva 
Orthos伊hongrandiflorus 
Persea Americana 
Allium cepa 
Fabaceae 
Fumariaceae 
Juglandaceae 
Lamiaceae 
Lamiaceae 
Lauraceae 
Liliaceae po,sc,ip,iv ap,bl 
N 
?
??
po 
po,iv,ip 
po, ip 
po,iv 
bl 
rz 
lf,sd 
If 
5 
?
?
??
?
?
Allium sativum 
Aloe vera 
Anemαrrhena asphodeloides 
Azadirachta indica 
Liliaceae 
Liliaceae 
Liliaceae 
お1eliaceae
N 
N 
po 
po,sc,ip 
rb,rt 
lf,rb 
3 
4 
Ficus religiosa 
Morus alba 
Moraceae 
Moraceae 
Active constituents 
calyptoside 
antimellin 
scopoletin 
coumarm 
tormentic acid 
Toxicity 
???
?
??
Route 
po,ip 
po 
po 
po 
po 
po,ip 
po 
ET恥fPart tested 
ap,sd 
If 
sy 
rt 
?
??
lf 
???
?
『?】?
?
『?
?
〕
Scientific name 
Eu caかptusglobulus 
Syzygium cumini 
Olea europaea 
Zea mays 
Polygonum aviculare 
Poterium ancistroides 
Capraria biflora 
Rehmannia glutinosa 
?????
? ?
???
?
．?
? ?
?
? ?
???
? ?
??
??
? ??? ?? ???
?
?
?
??
?
? ?
Family 
rehmannioside D, 
rehmanin ?
?3 
5 
Scoparia dulcis 
Urtica dioica 
。
?
??? ?
?
??．??
?
?
?
??
?
??
? po 
Q2 
The information is drawn mostly from NAPRALLERT databas巴，Collegeof Pharmacy, University of Ilinois at Chicago, 
USA. ETH number refers the number of countries where the plant is used as traditional medicine to treat diabetes. Part 
tested: ap: areal part, bl: bulb, fl: flower, fr: fruit, gm: gum, lf: leaf, rb: root b紅k,rt: rot, rz: rhizome, sb:stem bark, sd: 
seed, st: stem, sy: style, wp: whole plant; ToxiciηT: toxic, N: nontoxic (Mades and Fransworth, 1995). 
wp 
WQ 
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DISCUSSION 
In the present review, an attempt was made to list up the plants which are used by the people as an 
ethnomedicine in three or more countries. Fourty seven medicinal plants are found as the antidiabetic 
drugs used in three or more countries (Table 1). Aveηfew plants ( 13 plants) were studied in the clinical 
trail (Table 2). Many of the plants are used widely as the traditional medicine but no clinical trial record 
were found. It is interesting to know that Momordica charantia fruit is used in more than 12 countries but 
so far only two clinical trails are reported. Other widely used plants are Catharanthus roseus and 
Anacardium occidentale which are used in 10 and 9 countries, respectively and interestingly, no clinical 
trail report was found. Other widely used traditional antidiabetic drugs were Lupinus albus, Allium cepa, 
Allium sativum, Aloe vera, Eucalyptus globulus, Syzygium cumini. The Frati et al. performed clinical 
trial on Opunita streptacantha, and found acute hypoglycemic effect on NIDDM but without blinding or 
randomization effect (Ernst, 1997). There are several constituents for their alleged hypoglycemic effect re-
ported from the antidiabetic plants (Table 1 ).The detail study on them would also be an important line 
of research. 
Table 2: Antidiabetic Plants Tested Clinically 
Family Scientific nam巴 Sample Dose Reference 
Asclepiadac巴aeGymnema sylvestre 22 NIDDM 400 mg plant ext/d for 18-20 M Baskaran et al. (1990) 
Cactaceae Opunita streptacantha 14 NIDDM 500 g Frati et al. (1990) 
14 HV 
Cactaceae Opunita streptacantha 8 NIDDM 500 g broiled stem Frati et al. (1991) 
6HV 2x500 g hourly 
Cactaceae Opunita streptacantha 26 NIDDM 500 g broiled stem Frati・恥1unariet al. (1988) 
Cactaceae Opunita streptacantha 8 NIDDM 100, 300 & 500 g 
broiled stem Frati-Munari et al. (1988a) 
Cactaceae Opunita streptαcantha 8 NIDDM 500 g broiled stem Frati-Munari et al. (1988b) 
Cactaceae Opunita streptacantha 24 NIDDM 30 cap/d Frati-Munari et al. (1992) 
Cucurbitaceae Momordica charantia 9NIDDM a) 50 ml fruit juice Leatherdale et al. (1981) 
b) 230 g fried fruit 
Cucurbitaceae Momordica charantia NIDD島f ワ W elihanda et al. (1986) 
Fabaceae Acaciαcoriαcea 6HV 18 g flour Thorburn et al. (1987) 
Fabaceae Bauhinia forficate 6NIDD恥f 3 g leaf/d, for 56d 
Fabaceae Trigonella 21 NIDDM 15 g ground seed in meal Madar et al. (1988) 
foenum-graecum 
Liliaceae Aloe barbadensis 5 NIDDM 見teaspoon/d 
for 4-14 weeks Ghannam (1986) 
Family Scientific name Sample Dose Reference 
Liliaceae Allium cepa 6HV 125 mg essential oil/kg bw Augusti et al. (1975) 
Liliaceae Allium sativum 30HV 800 mg dried powder for 35 d Kiesewetter (1991) 
Moraceae Artocarpus heterophyllus ? 20 g/kg bw Fernando et al. (1991) 
Acanthaceae Asteracanthus longifolia ? 20 g/kg bw Fernando et al. (1991) 
f下 Cynar，αscolymus 3 NIDDM 150 g mashed plant/d Mescherikova et al. (1995) 
Myricaceae Myrica uniflora 18 NIDDM 3 g leaf/d for 56 d Russo et al.(1990) 
A Medline search was conducted (mesh headings, diabetes, hypoglycemic, plants, herbs, phytomedicin巴）.All ab-
stracts thus found were uncanned for clinical trails. Publication related to case reports or historical uses were 
discarded. Papers in any languages other than English, French or German were巴xcluded.HV: healthy volunteer; 
NIDDM: Noninsulin Dependent Diabet巴SMellitus (Ernst, 1997). 
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COM島IENT
Phytomedicines are frequently used酪紅白佃ientfor diabetes in many cultures (Eisenberg et al., 1993; 
Bailey et al., 1989; Rahman et al., 1989; Bever et al., 1979; Jahodar, 1993; Lin, 1992; Yaniv et al., 1987). 
More血an1200 species of plants have been used traditionally or studied for their alleged hypoglycemic 
effects (Marles組 dFransworth, 1995). There紅emore than 1500 prescription suggested for the clinical 
use in traditional Chinese medicine. It is interesting to note血atwith only a few exceptions, there紅eno 
attempts of replicating the results. Similarly, results from previous studies (Bever et al., 1979) have not 
been followed up.百iereare so many researches to find antidiabetic drugs but not a single herbal medicine 
is accepted clinically in general. The question is why? It is not血atpeople are not using. It is not由atdoc-
tors are not suggesting. It is not that patients are not benefiting仕omthe herbal佐・eatment.The main prob-
lem is that there is no any study in details on any p釘ticularherbal medicines in depth. Herbal medicines 
are not properly described for their doses, mode of administration, action mechanism, risk and benefit, 
bioavalbility, which紅every important to be used for the clinical凶al.
Some of the remedies町eknown to be associated with potential risk. Momordica charantia, for instance, 
has recently been shown to be hepatotoxic in rats (Tannekoon, 1994), however, it is widely used vegetable 
in血emany of the Asian countries. Hypoglycemic coma has been reported after an overdose of 
Momordica charantia (Hulin et al., 1988）.百ierisk-benefit, quality, doses, use for typical diabetic condi-
tion have not been reported any where. Such trend of research defame the herbal treatment. In addition 
to世tis,the safety issue is further complicated by the fact that non-medically trained herbalists may give 
incomplete advice to diabetic patients seriously endangering their health (Gills et al., 1994; Zimmer et al., 
1994). 
百iereare already several scientific evidences for the cause of diabetes mellitus and one m吋orcause is由e
gradual destruction of insulin-producing {3 -cells in the pancreas. On this regard, the role of glu白micacid 
decarboxylase(GAD）・65,Insulin receptor substrate (IRS），官iland百i2cells activities, and reactive oxy-
gen spices (ROS) including SOD-activity, on diabetes mellitus have been studied. Vitamin C, vitamin E, 
nicotinamide, lipoic acid, N-acetyl-L-cysteine are some of the substances showing the preventive action 
on diabetes. However, there is no systematic study on the role of natural medicines and their actions in 
preventing diabetes. Therefore, besides hypoglycemic activity, protection to {3-cells in血epancreas, re-
generation of {3-cells, are also important line of researches of antidiabetic plants. 
At present, no antidiabetic phytomedicine can be recommended for clinical use. Rigorous investigation, 
preferably through rand01nized con仕olledtrails could however prove to be fruiぜul.Twenty first century 
demands a systematic research on natural medicine to provide potential evidence based antidiabetic drugs. 
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